Novacyt (NCYT) Hits New 1-Year Low at $15.00

Novacyt SA (LON:NCYT) shares reached a new 52-week low on Wednesday . The company traded as low as GBX 15 ($0.20) and last traded at GBX 15 ($0.20), with a volume of 169 shares changing hands. The stock had previously closed at GBX 15 ($0.20).

The company has a debt-to-equity ratio of 26.69, a current ratio of 1.01 and a quick ratio of 0.52. The firm has a market cap of $3.46 million and a price-to-earnings ratio of -0.57.

ILLEGAL ACTIVITY NOTICE: This news story was posted by WKRB News and is the sole property of of WKRB News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at

About Novacyt (LON:NCYT)

Novacyt SA develops and sells diagnostic products for cancer and infectious diseases. The company's diagnostic products are used in liquid based cytology, oncology, microbiology, haematology, and serology testing. It offers NovaPrep, a liquid based cytology solution that is utilized in the diagnosis of cervical cancer; and clinical laboratory testing services to clinicians, healthcare providers, and patients.

Recommended Story: Marijuana Stocks

Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with's FREE daily email newsletter.